BKS Uni
Commercial- Indications
- Unicompartmental knee arthritis
Company intelligence / Profile preview
Ortho Development has a robust portfolio of FDA-cleared orthopedic implants and surgical instruments for hip, knee, spine, and trauma applications. Recent clinical results include the successful launch of the Trivicta™ Hip System with 510(k) clearance in 2024. The Balanced Knee® System has over 20 years of clinical history.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ortho Development.